Santen RJ - Search Results

1

CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.

Rahman M, Lax SF, Sutter CH, Tran QT, Stevens GL, Emmert GL, Russo J, Santen RJ, Sutter TR. Rahman M, et al. Among authors: santen rj. Drug Metab Dispos. 2008 May;36(5):963-70. doi: 10.1124/dmd.107.018960. Epub 2008 Feb 6. Drug Metab Dispos. 2008. PMID: 18256205 Free PMC article.

2

Tissue-specific synthesis and oxidative metabolism of estrogens.

Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G, Berstein L. Jefcoate CR, et al. Among authors: santen rj. J Natl Cancer Inst Monogr. 2000;(27):95-112. doi: 10.1093/oxfordjournals.jncimonographs.a024248. J Natl Cancer Inst Monogr. 2000. PMID: 10963622 Review.

3

Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T. Cavalieri E, et al. Biochim Biophys Acta. 2006 Aug;1766(1):63-78. doi: 10.1016/j.bbcan.2006.03.001. Epub 2006 Apr 19. Biochim Biophys Acta. 2006. PMID: 16675129 Review.

4

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.

Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Santen R, et al. Ann N Y Acad Sci. 2009 Feb;1155:132-40. doi: 10.1111/j.1749-6632.2008.03685.x. Ann N Y Acad Sci. 2009. PMID: 19250200 Review.

5

Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible?

Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM, Hamilton C, Yue W, Wang JP. Santen RJ, et al. J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):267-71. J Steroid Biochem Mol Biol. 1997. PMID: 9365200

6

Use of aromatase inhibitors in breast carcinoma.

Santen RJ, Harvey HA. Santen RJ, et al. Endocr Relat Cancer. 1999 Mar;6(1):75-92. doi: 10.1677/erc.0.0060075. Endocr Relat Cancer. 1999. PMID: 10732791 Review.

7

Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.

Come SE, Buzdar AU, Ingle JN, Arteaga CL, Brodie AM, Colditz GA, Johnston SR, Kristensen VN, Lønning PE, McDonnell DP, Osborne CK, Russo J, Santen RJ, Yee D, Hart CS. Come SE, et al. Among authors: santen rj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):861s-4s. Clin Cancer Res. 2005. PMID: 15701878 No abstract available.

8

Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.

Harvey JA, Santen RJ, Petroni GR, Bovbjerg VE, Smolkin ME, Sheriff FS, Russo J. Harvey JA, et al. Among authors: santen rj. Menopause. 2008 Jan-Feb;15(1):67-73. doi: 10.1097/gme.0b013e318054e29a. Menopause. 2008. PMID: 17558338 Free PMC article.

9

Aromatase expression in atypical ductal hyperplasia in women.

Santen RJ, Radisky DC, Degnim A, Frost MH, Vachon CM, Ghosh K, Guestini F, McNamara KM, Sasano H. Santen RJ, et al. Breast Cancer Res Treat. 2017 Jun;163(3):623-629. doi: 10.1007/s10549-017-4184-x. Epub 2017 Mar 23. Breast Cancer Res Treat. 2017. PMID: 28337664 Free PMC article.

10

Clinical use of aromatase inhibitors in human breast carcinoma.

Santen RJ. Santen RJ. J Steroid Biochem Mol Biol. 1991;40(1-3):247-53. doi: 10.1016/0960-0760(91)90189-c. J Steroid Biochem Mol Biol. 1991. PMID: 1835644 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page